Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation

Masayuki Hashimoto, Toranoshin Ayada, Ichiko Kinjyo, Kiyokazu Hiwatashi, Hideyuki Yoshida, Yasunori Okada, Takashi Kobayashi, Akihiko Yoshimura

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Inflammation has been shown to contribute to both tumor development and antitumor immunity. However, conditions determining these opposing effects are not well understood. Suppressor of cytokine signaling 1 (SOCS1) has been shown to play an important role in regulating inflammation and tumor development. It has been reported that silencing of SOCS1 gene in dendritic cells potentiates antitumor immunity, while SOCS1-deficiency in whole organs except for T and B cells enhances inflammation-mediated colon tumor development. To determine which types of cells are important for the suppression of tumor development by SOCS1-deficiency, we employed the conditional knockout strategy. SOCS1 gene was deleted in macrophages and neutrophils by crossing SOCS1-flox/ flox mice with LysM-cre mice. Resulting conditional knockout (cKO) mice showed enhanced sensitivity to endotoxin shock. SOCS1-cKO mice survived much longer than wild-type mice after B16 melanoma transplantation. Colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH) plus dextran sulfate sodium (DSS) was also reduced in SOCS1-cKO mice. SOCS1-deficiency in monocytic cells enhanced tumor-killing activity of macrophages and tumor-specific cytotoxic T cell activity. These results suggest that inflammation induced by SOCS1-deficiency in monocytes potentiates antitumor immune responses rather than tumor-promoting inflammation.

Original languageEnglish
Pages (from-to)730-736
Number of pages7
JournalCancer Science
Volume100
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Macrophages
Cytokines
Inflammation
Neoplasms
Knockout Mice
Immunity
Colon
1,2-Dimethylhydrazine
T-Lymphocytes
Dextran Sulfate
Experimental Melanomas
Endotoxins
Dendritic Cells
Genes
Monocytes
Shock
Carcinogenesis
Neutrophils
B-Lymphocytes
Transplantation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. / Hashimoto, Masayuki; Ayada, Toranoshin; Kinjyo, Ichiko; Hiwatashi, Kiyokazu; Yoshida, Hideyuki; Okada, Yasunori; Kobayashi, Takashi; Yoshimura, Akihiko.

In: Cancer Science, Vol. 100, No. 4, 2009, p. 730-736.

Research output: Contribution to journalArticle

Hashimoto, M, Ayada, T, Kinjyo, I, Hiwatashi, K, Yoshida, H, Okada, Y, Kobayashi, T & Yoshimura, A 2009, 'Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation', Cancer Science, vol. 100, no. 4, pp. 730-736. https://doi.org/10.1111/j.1349-7006.2009.01098.x
Hashimoto, Masayuki ; Ayada, Toranoshin ; Kinjyo, Ichiko ; Hiwatashi, Kiyokazu ; Yoshida, Hideyuki ; Okada, Yasunori ; Kobayashi, Takashi ; Yoshimura, Akihiko. / Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. In: Cancer Science. 2009 ; Vol. 100, No. 4. pp. 730-736.
@article{2ed9408d7e5c42e29aff80d9ddc0884c,
title = "Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation",
abstract = "Inflammation has been shown to contribute to both tumor development and antitumor immunity. However, conditions determining these opposing effects are not well understood. Suppressor of cytokine signaling 1 (SOCS1) has been shown to play an important role in regulating inflammation and tumor development. It has been reported that silencing of SOCS1 gene in dendritic cells potentiates antitumor immunity, while SOCS1-deficiency in whole organs except for T and B cells enhances inflammation-mediated colon tumor development. To determine which types of cells are important for the suppression of tumor development by SOCS1-deficiency, we employed the conditional knockout strategy. SOCS1 gene was deleted in macrophages and neutrophils by crossing SOCS1-flox/ flox mice with LysM-cre mice. Resulting conditional knockout (cKO) mice showed enhanced sensitivity to endotoxin shock. SOCS1-cKO mice survived much longer than wild-type mice after B16 melanoma transplantation. Colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH) plus dextran sulfate sodium (DSS) was also reduced in SOCS1-cKO mice. SOCS1-deficiency in monocytic cells enhanced tumor-killing activity of macrophages and tumor-specific cytotoxic T cell activity. These results suggest that inflammation induced by SOCS1-deficiency in monocytes potentiates antitumor immune responses rather than tumor-promoting inflammation.",
author = "Masayuki Hashimoto and Toranoshin Ayada and Ichiko Kinjyo and Kiyokazu Hiwatashi and Hideyuki Yoshida and Yasunori Okada and Takashi Kobayashi and Akihiko Yoshimura",
year = "2009",
doi = "10.1111/j.1349-7006.2009.01098.x",
language = "English",
volume = "100",
pages = "730--736",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation

AU - Hashimoto, Masayuki

AU - Ayada, Toranoshin

AU - Kinjyo, Ichiko

AU - Hiwatashi, Kiyokazu

AU - Yoshida, Hideyuki

AU - Okada, Yasunori

AU - Kobayashi, Takashi

AU - Yoshimura, Akihiko

PY - 2009

Y1 - 2009

N2 - Inflammation has been shown to contribute to both tumor development and antitumor immunity. However, conditions determining these opposing effects are not well understood. Suppressor of cytokine signaling 1 (SOCS1) has been shown to play an important role in regulating inflammation and tumor development. It has been reported that silencing of SOCS1 gene in dendritic cells potentiates antitumor immunity, while SOCS1-deficiency in whole organs except for T and B cells enhances inflammation-mediated colon tumor development. To determine which types of cells are important for the suppression of tumor development by SOCS1-deficiency, we employed the conditional knockout strategy. SOCS1 gene was deleted in macrophages and neutrophils by crossing SOCS1-flox/ flox mice with LysM-cre mice. Resulting conditional knockout (cKO) mice showed enhanced sensitivity to endotoxin shock. SOCS1-cKO mice survived much longer than wild-type mice after B16 melanoma transplantation. Colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH) plus dextran sulfate sodium (DSS) was also reduced in SOCS1-cKO mice. SOCS1-deficiency in monocytic cells enhanced tumor-killing activity of macrophages and tumor-specific cytotoxic T cell activity. These results suggest that inflammation induced by SOCS1-deficiency in monocytes potentiates antitumor immune responses rather than tumor-promoting inflammation.

AB - Inflammation has been shown to contribute to both tumor development and antitumor immunity. However, conditions determining these opposing effects are not well understood. Suppressor of cytokine signaling 1 (SOCS1) has been shown to play an important role in regulating inflammation and tumor development. It has been reported that silencing of SOCS1 gene in dendritic cells potentiates antitumor immunity, while SOCS1-deficiency in whole organs except for T and B cells enhances inflammation-mediated colon tumor development. To determine which types of cells are important for the suppression of tumor development by SOCS1-deficiency, we employed the conditional knockout strategy. SOCS1 gene was deleted in macrophages and neutrophils by crossing SOCS1-flox/ flox mice with LysM-cre mice. Resulting conditional knockout (cKO) mice showed enhanced sensitivity to endotoxin shock. SOCS1-cKO mice survived much longer than wild-type mice after B16 melanoma transplantation. Colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH) plus dextran sulfate sodium (DSS) was also reduced in SOCS1-cKO mice. SOCS1-deficiency in monocytic cells enhanced tumor-killing activity of macrophages and tumor-specific cytotoxic T cell activity. These results suggest that inflammation induced by SOCS1-deficiency in monocytes potentiates antitumor immune responses rather than tumor-promoting inflammation.

UR - http://www.scopus.com/inward/record.url?scp=67449083552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449083552&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2009.01098.x

DO - 10.1111/j.1349-7006.2009.01098.x

M3 - Article

C2 - 19469017

AN - SCOPUS:67449083552

VL - 100

SP - 730

EP - 736

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 4

ER -